Peptide Classification: Analogues, Conjugates, Mimetics and Complexes
Classification is not filing. The category a compound belongs to predicts how it is made, how it degrades, how it must be analysed and how far its literature can be trusted to transfer.
Native peptides
A sequence that occurs in biology, made synthetically. Oxytocin, LL-37 and kisspeptin-10 are examples. Their advantage as research materials is that endogenous physiology is often well characterised, so there is a genuine reference point for what the molecule does.
Their practical disadvantage is instability. Native sequences are substrates for the proteases that evolved alongside them, which is why native GLP-1 has a half-life of minutes.
Peptide analogues
A native sequence deliberately altered to change its properties. Semaglutide is GLP-1 with substitutions resisting DPP-4 cleavage and a fatty-acid chain promoting albumin binding. Pramlintide is human amylin with proline substitutions borrowed from the rat sequence to stop it aggregating. Desmopressin is vasopressin modified for receptor selectivity and duration.
The important consequence for a reader: literature about the native hormone does not automatically apply to the analogue, and vice versa. The modifications exist precisely because they change behaviour.
Conjugates and complexes
A conjugate attaches a non-peptide component — a fatty acid, a polymer, a drug-affinity complex. CJC-1295 with DAC is the clear case: the drug-affinity complex binds covalently to albumin and extends duration from minutes to days. The version without it is a different compound with different pharmacokinetics, and the two are constantly confused.
A metal–peptide complex is different again. In GHK-Cu the copper(II) ion is part of the chemical species, not a contaminant. Analysing only the tripeptide tells you nothing about whether the complex was supplied, which is why the right analytical check uses UV-visible absorbance alongside mass spectrometry.
Mimetics and non-natural backbones
A peptide mimetic reproduces a peptide's interaction using a structure that is not a peptide. It will not behave like a peptide in synthesis, degradation or analysis, and classifying it as one is simply an error.
Retro-inverso designs sit between the categories. FOXO4-DRI reverses the sequence and builds it from D-amino acids, producing a side-chain arrangement resembling the parent while being largely invisible to proteases, which act on L-peptides. It is a peptide by bond type and something quite different by behaviour.
Mixtures
A blend is two or more compounds in one vial. It has no single molecular mass, no single CAS number and no single purity figure — each component needs characterising separately. A certificate reporting one purity number for a blend is not telling you what you need to know, and a page describing a blend as though it were a molecule is misleading whether or not that was the intent.
Compounds referenced
Related reading
What Are Research Peptides? A Scientific Introduction
What distinguishes a peptide from a protein, why "research peptide" is a regulatory category rather than a chemical one, and how to read claims made about these compounds.
How to Read a Peptide Certificate of Analysis
A section-by-section guide to COAs: what each figure means, which claims a certificate can support, and the gaps that most often go unnoticed.
Peptide Stability, Degradation and Storage
The chemical routes by which peptides degrade — hydrolysis, oxidation, deamidation, aggregation — and what storage and handling practice follows from them.